Gabriella Mezei
Debrecen, HB 4002, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Treatment-Emergent Resistance to Asciminib in Chronic Myeloid Leukemia Patients Due to Myristoyl-Binding Pocket-Mutant of BCR::ABL1/A337V Can Be Effectively Overcome with Dasatinib Treatment.
Journal: Current oncology (Toronto, Ont.)
Published: December 24, 2024
Successful ruxolitinib rechallenge after fedratinib failure in a patient with overt myelofibrosis.
Journal: Annals of hematology
Published: April 07, 2024
Imidazo[1,2-b]pyrazole-7-Carboxamide Derivative Induces Differentiation-Coupled Apoptosis of Immature Myeloid Cells Such as Acute Myeloid Leukemia and Myeloid-Derived Suppressor Cells.
Journal: International journal of molecular sciences
Published: May 28, 2020
Dasatinib Inhibits Procoagulant and Clot Retracting Activities of Human Platelets.
Journal: International journal of molecular sciences
Published: September 16, 2019
Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia.
Journal: Platelets
Published: August 02, 2018
Drug treatment of acute myelogenous leukaemia. Current options and future perspectives
Journal: Orvosi hetilap
Published: May 24, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026